GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » New Journey Health Technology Group Co Ltd (SZSE:002219) » Definitions » Debt-to-Equity

New Journey Health Technology Group Co (SZSE:002219) Debt-to-Equity : 0.78 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is New Journey Health Technology Group Co Debt-to-Equity?

New Journey Health Technology Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥988 Mil. New Journey Health Technology Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥763 Mil. New Journey Health Technology Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,247 Mil. New Journey Health Technology Group Co's debt to equity for the quarter that ended in Mar. 2024 was 0.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for New Journey Health Technology Group Co's Debt-to-Equity or its related term are showing as below:

SZSE:002219' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04   Med: 0.82   Max: 28.54
Current: 0.78

During the past 13 years, the highest Debt-to-Equity Ratio of New Journey Health Technology Group Co was 28.54. The lowest was 0.04. And the median was 0.82.

SZSE:002219's Debt-to-Equity is ranked worse than
79.57% of 847 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs SZSE:002219: 0.78

New Journey Health Technology Group Co Debt-to-Equity Historical Data

The historical data trend for New Journey Health Technology Group Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Journey Health Technology Group Co Debt-to-Equity Chart

New Journey Health Technology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.63 18.13 1.57 0.92 0.79

New Journey Health Technology Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.78 0.83 0.79 0.78

Competitive Comparison of New Journey Health Technology Group Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, New Journey Health Technology Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Journey Health Technology Group Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, New Journey Health Technology Group Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where New Journey Health Technology Group Co's Debt-to-Equity falls into.



New Journey Health Technology Group Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

New Journey Health Technology Group Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

New Journey Health Technology Group Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


New Journey Health Technology Group Co  (SZSE:002219) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


New Journey Health Technology Group Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of New Journey Health Technology Group Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


New Journey Health Technology Group Co (SZSE:002219) Business Description

Traded in Other Exchanges
N/A
Address
Duyiyi Industrial Park, Wangba, Kang County, Gansu Province, Longnan, CHN, 610000
New Journey Health Technology Group Co Ltd formerly Hengkang Medical Group Co Ltd is engaged in research, development, and manufacturing of natural herbal medicines. The company's products include analgesic and haemostatic drugs.
Executives
Song Li Hua Directors, executives
Yu Mei Directors, executives
Wang Yong Executives
Zuo Bin Lin Executives
Tang Can Director
Duan Zhi Ping Director
Zhou Xian Min Director
Guo Kai Executives
Xie Hai Executives
Shi Xiao Ming Executives
Li Yu Fei Supervisors
Huang Rui Directors, executives
Pan Yu Supervisors
Liao Li Dong Executives

New Journey Health Technology Group Co (SZSE:002219) Headlines

No Headlines